Tabcat-bha
Tabcat-bha has been studied in 3 papers since 2025: 3 observational studies in people; 2 in the past year. The newest paper, Jan 9, 2026: “Digital Cognitive Markers to Characterize Preclinical Stages of autosomal‐dominant Alzheimer's Disease: A Preliminary Study”.
3 papers study it1 findingUpdated
“the TabCAT-BHA demonstrated greater accuracy in detecting cognitive impairment (AUC = 75.3%) compared to the MMSE (AUC = 66.4%) and RUDAS (AUC = 71.4%)”
- 1 lab in 1 country
- Funders: Fogarty International Center and 2 more
- Humans3
What is Tabcat-bha linked with?
1Studies link Tabcat-bha with 1 measure, most often cognitive impairment (1 study).
Cognitive impairment
upin humans1
1 study
Cognitive impairment
upin humans1
Tabcat-bha predicts cognitive impairment in humans (AUC = 75.3% vs MMSE 66.4% and RUDAS 71.4%).
“the TabCAT-BHA demonstrated greater accuracy in detecting cognitive impairment (AUC = 75.3%) compared to the MMSE (AUC = 66.4%) and RUDAS (AUC = 71.4%)”
Humansn = 258
Peruvian validation and standardization of the TabCAT-brain health assessment
Frontiers in public health
Latest
2 papers in 12 monthsAAIC 2025 Abstract
Digital Cognitive Markers to Characterize Preclinical Stages of autosomal‐dominant Alzheimer's Disease: A Preliminary Study
Cross-sectional study of 135 peopleAlzheimer's disease
AAIC 2025 Abstract
TabCAT Brain Health Assessment for Detecting Cognitive Impairment in Israeli Arabs. Discriminant and Concurrent Validity with Standard Tools
Case-control study in peopleCognitive impairment
Frontiers in Public Health
Peruvian validation and standardization of the TabCAT-brain health assessment
Cross-sectional study of 258 peopleBiomarkers